Monopar Therapeutics Inc MNPR
NASDAQ · United States · Health Technology
$77.970.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.62 | -0.65 | +4.2% | $0 | — | -3.5%$114.46→$110.41 |
| Q1 2026 | 2026-05-14 | -0.46 | -1.06 | +56.6% | — | — | -3.5%$61.44→$59.27 |
| Q4 2025 | 2026-03-27 | -0.61 | -0.51 | -19.6% | — | — | -2.3%$54.56→$53.29 |
| Q3 2025 | 2025-11-13 | -0.48 | -0.46 | -4.3% | — | — | -5.5%$82.58→$78.00 |
| Q4 2024 | 2025-03-31 | -2.75 | -0.42 | -554.8% | — | — | — |
| Q3 2024 | 2024-11-08 | -1.85 | -1.17 | -58.1% | — | — | — |
| Q2 2024 | 2024-08-09 | -0.50 | -0.47 | -6.4% | — | — | — |
| Q4 2023 | 2024-03-28 | -0.60 | -0.85 | +29.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.